The Essence of Basic Research Innovation At CLYTE
The name CLYTE is a fusion of Clytie and Cyte, embodying both mythology and science. # CLYTE Definition & Meaning
Clytie—also known as Clytia—was a water nymph in Greek mythology, deeply connected to the sun and its cycles. Transformed into a sunflower, she came to symbolize growth, renewal, and the relentless pursuit of knowledge. Cyte, derived from cellular biology, refers to cells—the fundamental units of life and the focus of scientific exploration.
Phonetically, CLYTE echoes the word light, a timeless symbol of illumination, discovery, and insight—values at the heart of research and innovation.
This carefully crafted name reflects the company’s commitment to life sciences and biomedical research, rooted in a passion for progress, discovery, and the advancement of knowledge.
The Story Behind the Name CLYTE
CLYTE's Journey of Innovation
Early 2024 we started official development of our first product CellCut 1.0. A simple tool for applying uniform and unique scratches for 2D scratch assays. Currently under "First-client initiative" the tool has received overwhelmingly positive feedback, by allowing standardized and uniform scratches which eliminates human user application variability in the assessment of the assay.
In Sprint of 2025 our flagship AI model SOφ (Sophie) was developed; published in August of 2025 for researchers and students to use cutting-edge AI for assay design, analysis, and troubleshooting.
On May 2024 our biggest and most ambitious project was started. Cadmus a tool for cell culture monitoring, began development on May and version 0.5 of the device was tested internally. Following 50+ customer discoveries and user feedback, the new version of the device is currently under development with prospect of release for "First-client initiative" for Winter 2026, and mass market release in Q4.
Over 2025 we aim to expand our "First-client initiative" and release online services and tools for research data analysis.
CLYTE also hope to gain support of allies, industry leaders, and investors to finalize project Cadmus for market release in 2026; A project with immense impact on healthcare industry, utilizing AI in healthcare, and reforming how cell cultures are done not only in basic research side (drug development and testing, immunity research, etc.), but also in patient care, with reducing culture failures in procedures such as cell therapy and personalized cancer treatments.
Next Steps For CLYTE
CLYTE's Mission of Research Standardization
Basic research is the foundation for progress across all fields. In biomedical and life sciences, it drives groundbreaking discoveries that tackle some of the most significant challenges to human health.
Nevertheless, many preclinical research procedures are extremely time consuming, redundant, and may result in non-reproducible data!
CLYTE is an AI Biotechnology startup, aiming to reform those procedures to make them efficient, timely, and standardized, using AI in healthcare and cutting-edge technologies.